KANGJI MED.HLDS DL-,00001 financial statements, including revenue, expenses, profit, and loss
The total revenue of 50J for the last semiannual is 65.47 M EUR, and it's 22.64% higher compared to the previous semiannual. The net income of H2 23 is 31.15 M EUR.